Utilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer Patients
Our Lady of the Lake Hospital · NCT06659458
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- January 1, 2025
- Record last updated
- March 20, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
EGFR gene mutations are some of the most commonly occurring mutations in non-small cell lung cancer. Investigators have developed a DNA instability model that estimates a risk score to assess the likelihood of an individual acquiring a cancer-linked mutation. The aim of this study is to collect blood from both those diagnosed with EGFR positive lung cancer and healthy individuals, evaluate their gene sequence surrounding the EGFR landscape and use the cancer positive and healthy sequences to validate the risk assessment model, which may one day be used to provide insight on susceptibility of getting EGFR positive lung cancer or potentially other cancer types.
Being studied: blood draw; Gene sequencing
Conditions: Lung Cancer - Non Small Cell; EGFR Exon 19 Deletion Mutation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18-100 years old
- Biologically born female
- Diagnosed with EGFR positive lung cancer (Arm 1-Cancer group)
- No cancer diagnosis (Arm 2-health control)
Exclusion Criteria
- less than 18 years of age
- Biologically born male
- Incarcerated at the time of participation
Recruiting US locations
Our Lady of the Lake Regional Medical Center
Baton Rouge, LA 70808
Study contacts (from the official record)
- Cynthia Knox, MBA · 225-765-3344 · Cynthia.Knox@fmolhs.org
- Christine LeBoeuf, DNP · 225-763-5956 · Christine.Leboeuf@fmolhs.org
Similar studies in Louisiana
All healthy volunteers studies in Louisiana →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- New Orleans, LA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII…
Equilibra Bioscience LLC
- Location
- Metairie, LA + 6 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals
- Location
- Marrero, LA + 4 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersOvernight stay mentioned
Experimental Approach to Test Predictions of Body Weight Regulation Models
Pennington Biomedical Research Center
- Location
- Baton Rouge, LA
- Eligibility basics
- Ages 18–40